Chr. Hansen experienced a strong second quarter and maintains the outlook for the year
“Following a strong Q2 with 10% organic growth and solid margin development we remain on track to deliver on our outlook for the full year, expecting organic revenue growth of 7-9% and an EBIT margin before special items above 26%,” says CEO Cees de Jong.
“We have continued to implement our Nature’s No. 1 strategy with initiatives to support the future growth and profitability of Chr. Hansen. I am especially pleased with the good performance of both the Cultures & Enzymes Division and the EMEA region in general as well as to see the first sales of cultures for crop protection.”
Highlights first half 2013/14
- Revenue EUR 353 million, unchanged from first half 2012/13
- Organic growth 6%
- EBIT before special items and impairments EUR 88 million and EBIT margin before special items and impairments 25.0%, both unchanged from last year
Second quarter 2013/14 results
- Revenue EUR 182 million, up 4% on last year
- Organic growth 10%
- EBIT margin before special items and impairments 24.8%, up from 23.3% last year
Outlook for 2013/14
The outlook for 2013/14 is unchanged from the announcement of 15 January 2014.
Organic revenue growth is expected to be 7‐9%.
The EBIT margin before special items is expected to be above 26%.
Full interim report
Please see the interim report for further details:
Chr. Hansen is a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on more than 30,000 microbial strains – we like to refer to them as ‘good bacteria’. Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which make our products highly relevant in today’s world. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for over 140 years. We are proud that more than one billion people consume products containing our natural ingredients every day. Revenue in the 2017/18 financial year was EUR 1,097 million. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen.